Skip to main content
. 2019 Apr 15;11(4):2470–2476.

Table 1.

Distribution of cell cycle phases of U251 receiving different treatments

SUB G0/G1 S G2/M
shNC 1.53 ± 1.05 65.63 ± 1.80 18.57 ± 2.12 14.27 ± 2.70
shSKP2 13.73 ± 1.90a 50.67 ± 1.42a 14.63 ± 2.04 21.80 ± 1.80a
shNC+TMZ 8.77 ± 1.33a,b 51.63 ± 3.44a 17.67 ± 1.11 21.93 ± 3.69a
shSKP2+TMZ 19.23 ± 1.40a,b,c 40.13 ± 4.69a,b,c 16.63 ± 1.25 25.00 ± 3.47a
a

P < 0.05 compared to shNC group;

b

P < 0.05 compared to shSKP2 group;

c

P < 0.05 compared to shNC+TMZ group.